Rankings
▼
Calendar
LXRX Q4 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14,000
-93.0% YoY
Gross Profit
-$16M
-117742.9% margin
Operating Income
-$25M
-180928.6% margin
Net Income
-$26M
-182935.7% margin
EPS (Diluted)
$-0.17
QoQ Revenue Growth
-39.1%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$137M
Total Liabilities
$23M
Stockholders' Equity
$114M
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14,000
$199,000
-93.0%
Gross Profit
-$16M
-$793,000
-1978.7%
Operating Income
-$25M
-$7M
-239.6%
Net Income
-$26M
-$5M
-366.1%
← FY 2021
All Quarters
Q1 2022 →